Opening book details…
About this Biochemistry, Genetics and Molecular Biology article
Single agent and synergistic activity of the "first in class" dual PI3K/BRD4 inhibitor SF1126 with Sorafenib in hepatocellular carcinoma by Singh, A. R.; Joshi, S.; Burgoyne, A. M.; Sicklick, J. K.; Ikeda, S.; Kono, Y.; Garlich, J. R.; Morales, G. A.; Durden, D. L. is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.
- Author
- Singh, A. R.; Joshi, S.; Burgoyne, A. M.; Sicklick, J. K.; Ikeda, S.; Kono, Y.; Garlich, J. R.; Morales, G. A.; Durden, D. L.
- Publisher
- American Association for Cancer Research; American Association for Cancer Research (AACR) (ISSN 1535-7163)
- Published
- 2016
- Language
- EN
- Field
- Biochemistry, Genetics and Molecular Biology (Life Sciences)